<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>united spinal's MS Scene</title>
	<atom:link href="http://www.unitedspinal.org/msscene/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.unitedspinal.org/msscene</link>
	<description>The larger view on multiple sclerosis</description>
	<pubDate>Tue, 09 Mar 2010 22:34:45 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Raising MS Awareness Year-Round</title>
		<link>http://www.unitedspinal.org/msscene/2010/03/09/raising-ms-awareness-year-round/</link>
		<comments>http://www.unitedspinal.org/msscene/2010/03/09/raising-ms-awareness-year-round/#comments</comments>
		<pubDate>Tue, 09 Mar 2010 22:31:35 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[Featured]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1558</guid>
		<description><![CDATA[By Tom Scott, United Spinal Association Staff Editor
March 8–14 marks National Multiple Sclerosis Awareness Week.
As we reflect upon the progress toward finding a potential cure for multiple sclerosis (MS), United Spinal is committed to continue helping individuals overcome this disease, improve their quality of life, and discover the very best treatment options.
United Spinal’s Multiple Sclerosis Quarterly Report [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2010/03/09/raising-ms-awareness-year-round/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Copaxone 15-Year Study in Patients With MS</title>
		<link>http://www.unitedspinal.org/msscene/2010/03/01/copaxone-15-year-study-in-patients-with-ms/</link>
		<comments>http://www.unitedspinal.org/msscene/2010/03/01/copaxone-15-year-study-in-patients-with-ms/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 14:24:41 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[News Alerts]]></category>

		<category><![CDATA[Studies]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1554</guid>
		<description><![CDATA[Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. recently announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis. 
The 15-year [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2010/03/01/copaxone-15-year-study-in-patients-with-ms/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Potential Therapy for Relapsing MS</title>
		<link>http://www.unitedspinal.org/msscene/2010/02/17/potential-therapy-for-relapsing-ms/</link>
		<comments>http://www.unitedspinal.org/msscene/2010/02/17/potential-therapy-for-relapsing-ms/#comments</comments>
		<pubDate>Wed, 17 Feb 2010 16:06:52 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[Clinical Trials]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1549</guid>
		<description><![CDATA[A new study published in the March edition of the Lancet Neurology highlights the therapeutic benefits of daclizumab, a humanized monoclonal antibody that shows promise in reducing the amount of new or enlarged brain lesions in patients with relapsing multiple sclerosis (MS).
Monoclonal antibodies are immune system proteins that bind to target cells triggering the immune [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2010/02/17/potential-therapy-for-relapsing-ms/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Acorda Announces FDA Approval for Oral Treatment to Improve Walking</title>
		<link>http://www.unitedspinal.org/msscene/2010/01/26/acorda-announces-fda-approval-for-oral-treatment-to-improve-walking/</link>
		<comments>http://www.unitedspinal.org/msscene/2010/01/26/acorda-announces-fda-approval-for-oral-treatment-to-improve-walking/#comments</comments>
		<pubDate>Tue, 26 Jan 2010 14:07:49 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[News Alerts]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1544</guid>
		<description><![CDATA[Source: Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for AMPYRA™ (dalfampridine), an oral treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA demonstrated efficacy in people with all four major types [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2010/01/26/acorda-announces-fda-approval-for-oral-treatment-to-improve-walking/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Mothers With MS May Be Unique in Their Management of Fatigue</title>
		<link>http://www.unitedspinal.org/msscene/2010/01/15/mothers-with-ms-may-be-unique-in-their-management-of-fatigue/</link>
		<comments>http://www.unitedspinal.org/msscene/2010/01/15/mothers-with-ms-may-be-unique-in-their-management-of-fatigue/#comments</comments>
		<pubDate>Fri, 15 Jan 2010 18:46:52 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[Studies]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1538</guid>
		<description><![CDATA[Source: East Carolina University, College of Human Ecology
Mothers with multiple sclerosis (MS) may be managing fatigue in strikingly different ways than well mothers or those with rheumatoid arthritis (RA), say researchers at East Carolina University. In spite of the debilitating fatigue that many people with MS regularly experience, the fatigue that mothers with MS experience [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2010/01/15/mothers-with-ms-may-be-unique-in-their-management-of-fatigue/feed/</wfw:commentRss>
		</item>
		<item>
		<title>iPhone Application Designed for Multiple Sclerosis Patients</title>
		<link>http://www.unitedspinal.org/msscene/2010/01/06/iphone-application-designed-for-multiple-sclerosis-patients/</link>
		<comments>http://www.unitedspinal.org/msscene/2010/01/06/iphone-application-designed-for-multiple-sclerosis-patients/#comments</comments>
		<pubDate>Wed, 06 Jan 2010 14:51:09 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[News Alerts]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1534</guid>
		<description><![CDATA[Source: Elite Circle Computing, LLC
A Pennsylvania-based company has just released a healthcare management application that targets multiple sclerosis (MS) patients to the App Store.
David Warden, who was diagnosed with MS in 2008, created an application called i-Inject that allows fellow patients to manage details of their healthcare. The application provides a place for users to [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2010/01/06/iphone-application-designed-for-multiple-sclerosis-patients/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Disorders That Mimic Multiple Sclerosis</title>
		<link>http://www.unitedspinal.org/msscene/2009/12/08/disorders-that-mimic-multiple-sclerosis/</link>
		<comments>http://www.unitedspinal.org/msscene/2009/12/08/disorders-that-mimic-multiple-sclerosis/#comments</comments>
		<pubDate>Tue, 08 Dec 2009 14:25:00 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[All Articles]]></category>

		<category><![CDATA[Featured]]></category>

		<category><![CDATA[United Homepage]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1520</guid>
		<description><![CDATA[Disorders That Mimic Multiple Sclerosis. If your case of MS does not fit the typical pattern, you need to be aware of the other disorders that can mimic MS.]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2009/12/08/disorders-that-mimic-multiple-sclerosis/feed/</wfw:commentRss>
		</item>
		<item>
		<title>FDA Denies Application for New MS Pill</title>
		<link>http://www.unitedspinal.org/msscene/2009/12/02/fda-denies-application-for-new-ms-pill/</link>
		<comments>http://www.unitedspinal.org/msscene/2009/12/02/fda-denies-application-for-new-ms-pill/#comments</comments>
		<pubDate>Wed, 02 Dec 2009 14:13:05 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[News Alerts]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1513</guid>
		<description><![CDATA[The U.S. Food and Drug Administration (FDA) has denied the New Drug Application (NDA) for Cladribine Tablets, EMD Serono&#8217;s proprietary investigational oral medication to treat the relapsing-remitting form of multiple sclerosis (MS).
&#8220;The company will work closely with the FDA to fully understand FDA&#8217;s concerns and define a path forward for a successful resubmission of this application [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2009/12/02/fda-denies-application-for-new-ms-pill/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Let&#8217;s Defeat MS Together-Shelley&#8217;s Story</title>
		<link>http://www.unitedspinal.org/msscene/2009/12/01/lets-defeat-ms-together-shelleys-story/</link>
		<comments>http://www.unitedspinal.org/msscene/2009/12/01/lets-defeat-ms-together-shelleys-story/#comments</comments>
		<pubDate>Tue, 01 Dec 2009 16:45:28 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[Featured]]></category>

		<category><![CDATA[Techguide Newsticker]]></category>

		<category><![CDATA[United Homepage]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1504</guid>
		<description><![CDATA[Shelley's Story - How United Spinal members have coped with and overcome the challenges of Multiple Sclerosis. This is the first in a series of stories from our members.]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2009/12/01/lets-defeat-ms-together-shelleys-story/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Leading MS Lifestyle Empowerment Organization Changes Name</title>
		<link>http://www.unitedspinal.org/msscene/2009/11/24/leading-ms-lifestyle-empowerment-organization-changes-name/</link>
		<comments>http://www.unitedspinal.org/msscene/2009/11/24/leading-ms-lifestyle-empowerment-organization-changes-name/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 12:35:44 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[News Alerts]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1500</guid>
		<description><![CDATA[Can Do Multiple Sclerosis is the new name of the nation’s leading provider of lifestyle empowerment programs for people with multiple sclerosis (MS) and their support partners, announced Kim Sharkey, CEO, Can Do MS.
Formerly The Heuga Center for Multiple Sclerosis, Can Do MS conducted months of research, assessments, planning and strategic development to position its [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2009/11/24/leading-ms-lifestyle-empowerment-organization-changes-name/feed/</wfw:commentRss>
		</item>
		<item>
		<title>MS More Aggressive in Children</title>
		<link>http://www.unitedspinal.org/msscene/2009/11/17/ms-more-aggressive-in-children/</link>
		<comments>http://www.unitedspinal.org/msscene/2009/11/17/ms-more-aggressive-in-children/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 14:58:42 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[Studies]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1498</guid>
		<description><![CDATA[Source: University of Buffalo, www.buffalo.edu
Magnetic resonance images (MRI) of patients diagnosed with multiple sclerosis in childhood show that pediatric onset multiple sclerosis is more aggressive, and causes more brain lesions, than MS diagnosed in adulthood, researchers at the University at Buffalo have reported.
Interestingly, however, patients with pediatric-onset MS &#8212; which comprise up to 5 percent [...]]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2009/11/17/ms-more-aggressive-in-children/feed/</wfw:commentRss>
		</item>
		<item>
		<title>High Internet Use of People With MS Could Lead to Innovative Treatment Strategies</title>
		<link>http://www.unitedspinal.org/msscene/2009/11/09/high-internet-use-of-people-with-ms-could-lead-to-innovative-treatment-strategies/</link>
		<comments>http://www.unitedspinal.org/msscene/2009/11/09/high-internet-use-of-people-with-ms-could-lead-to-innovative-treatment-strategies/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 16:41:47 +0000</pubDate>
		<dc:creator>tscott</dc:creator>
		
		<category><![CDATA[All Articles]]></category>

		<category><![CDATA[Studies]]></category>

		<category><![CDATA[Techguide Newsticker]]></category>

		<category><![CDATA[United Homepage]]></category>

		<guid isPermaLink="false">http://www.unitedspinal.org/msscene/?p=1480</guid>
		<description><![CDATA[High internet use by people with Multiple Sclerosis may lead to some very innovative treatment strategies.]]></description>
		<wfw:commentRss>http://www.unitedspinal.org/msscene/2009/11/09/high-internet-use-of-people-with-ms-could-lead-to-innovative-treatment-strategies/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
